Luther King Capital Management (LKCM)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $298M | Sell |
|
|||||
2025
Q1 | $382M | Sell |
|
|||||
2024
Q4 | $406M | Sell |
|
|||||
2024
Q3 | $488M | Sell |
|
|||||
2024
Q2 | $438M | Sell |
|
|||||
2024
Q1 | $466M | Sell |
|
|||||
2023
Q4 | $432M | Sell |
|
|||||
2023
Q3 | $443M | Sell |
|
|||||
2023
Q2 | $460M | Sell |
|
|||||
2023
Q1 | $522M | Sell |
|
|||||
2022
Q4 | $502M | Sell |
|
|||||
2022
Q3 | $468M | Sell |
|
|||||
2022
Q2 | $504M | Sell |
|
|||||
2022
Q1 | $558M | Sell |
|
|||||
2021
Q4 | $671M | Sell |
|
|||||
2021
Q3 | $584M | Sell |
|
|||||
2021
Q2 | $521M | Sell |
|
|||||
2021
Q1 | $477M | Sell |
|
|||||
2020
Q4 | $528M | Sell |
|
|||||
2020
Q3 | $522M | Sell |
|
|||||
2020
Q2 | $436M | Sell |
|
|||||
2020
Q1 | $343M | Sell |
|
|||||
2019
Q4 | $420M | Sell |
|
|||||
2019
Q3 | $377M | Sell |
|
|||||
2019
Q2 | $381M | Sell |
|
|||||
2019
Q1 | $356M | Sell |
|
|||||
2018
Q4 | $297M | Sell |
|
|||||
2018
Q3 | $326M | Sell |
|
|||||
2018
Q2 | $281M | Sell |
|
|||||
2018
Q1 | $292M | Sell |
|
|||||
2017
Q4 | $274M | Sell |
|
|||||
2017
Q3 | $277M | Sell |
|
|||||
2017
Q2 | $257M | Sell |
|
|||||
2017
Q1 | $229M | Sell |
|
|||||
2016
Q4 | $213M | Sell |
|
|||||
2016
Q3 | $250M | Sell |
|
|||||
2016
Q2 | $233M | Sell |
|
|||||
2016
Q1 | $231M | Sell |
|
|||||
2015
Q4 | $237M | Sell |
|
|||||
2015
Q3 | $207M | Sell |
|
|||||
2015
Q2 | $222M | Sell |
|
|||||
2015
Q1 | $241M | Sell |
|
|||||
2014
Q4 | $227M | Sell |
|
|||||
2014
Q3 | $223M | Buy |
|
|||||
2014
Q2 | $216M | Sell |
|
|||||
2014
Q1 | $221M | Sell |
|
|||||
2013
Q4 | $208M | Buy |
|
|||||
2013
Q3 | $171M | Buy |
|
|||||
2013
Q2 | $148M | Buy |
|